Health Care & Life Sciences » Biotechnology | NovaBay Pharmaceuticals Inc.

NovaBay Pharmaceuticals Inc. | Ownership

Companies that own NovaBay Pharmaceuticals Inc.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Bank of America, NA (Private Banking)
81,534
0.48%
0
0%
06/30/2018
The Vanguard Group, Inc.
26,910
0.16%
0
0%
06/30/2018
BlackRock Fund Advisors
13,908
0.08%
2,686
0%
06/30/2018
G1 Execution Services LLC
11,944
0.07%
11,944
0%
06/30/2018
UBS Securities LLC
3,065
0.02%
671
0%
06/30/2018
NVWM LLC
3,040
0.02%
0
0%
06/30/2018
IFP Advisors, Inc.
2,000
0.01%
2,000
0%
06/30/2018
BlackRock Investment Management LLC
1,268
0.01%
589
0%
06/30/2018
BDO Wealth Advisors LLC
320
0%
0
0%
06/30/2018
Morgan Stanley Smith Barney LLC (Private Banking)
300
0%
-300
0%
06/30/2018

About NovaBay Pharmaceuticals

View Profile
Address
2000 Powell Street
Emeryville California 94608
United States
Employees -
Website http://novabay.com
Updated 07/08/2019
NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in commercializing and developing products for eye care. Its products include Avenova, NeutroPhase, and CelleRx. The comapny was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.